20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T67944 | P38 MAP Kinase Inhibitor Ⅵ | p38 MAPK | |
p38 MAP Kinase Inhibitor Ⅵ is a potent p38 MAP Kinase inhibitor with anti-inflammatory activity. | |||
TP2269 | MAP kinase fragment [Multiple species] | Others | |
This Mitogen-activated protein kinase (MAP kinase) fragment has a peptide sequence of Lys-Tyr-Ile-His-Ser-Ala-Asn-Val-Leu. The MAP kinases are serine/threonine-specific protein kinases belonging to the CMGC (CDK/MAPK/GSK... | |||
T36011 | P38 MAP Kinase Inhibitor IV | p38 MAPK Inhibitor IV | |
p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38x, and p38δ, respectively, in vitro.[1] It also inhibits LPS-induced TNF-α an... | |||
T9504 | MAP4343 | Microtubule Associated | |
Map4343 is a 3-methyl ether derivative of pregnenolone. Map4343 binds to microtubule associated protein 2 (MAP2) in vitro and stimulates tubulin polymerization, resulting in enhanced neurite extension and protection of n... | |||
T60011 | HS220 | MAPK | |
HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival. | |||
T11942 | MAP4K4-IN-3 | Compound 17 | MAPK |
MAP4K4-IN-3 (Compound 17) may be a viable target for antidiabetic agents, a serine/threonine protein kinase. | |||
T22961 | MAP4 | Others | |
metabotropic glutamate receptor modulator | |||
T3350 | Selonsertib | GS-4997 | Apoptosis , ASK , MAPK |
Selonsertib (GS-4997) is an orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities. | |||
T15250 | ETC-206 | MNK | |
ETC-206 is a selective inhibitor of MNK1 and MNK2 (IC50s: 64 nM and 86 nM). | |||
T5190 | GS-444217 | GS 444217,GS444217 | Apoptosis , ASK , MAPK |
GS-444217 is a selective ATP-competitive inhibitor of apoptosis signal-regulating kinase 1 (ASK1, IC50: 2.87 nM). | |||
T3101 | NQDI-1 | NQDI1,NQDI 1 | Apoptosis , ASK , MAPK |
NQDI-1 (NQDI 1) is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50/Ki: 3 μM/500 nM). | |||
T5643 | NG25 | MAPK | |
NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively. | |||
T13099 | TC ASK 10 | ASK , MAPK | |
TC ASK 10 is a potent, selective and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1)(IC50 of 14 nM). | |||
T16987 | TAO Kinase inhibitor 1 | Others , MAPK | |
TAO Kinase inhibitor 1 delays mitosis and induces mitotic cell death. TAO Kinase inhibitor 1 is a selective and ATP-competitive thousand-and-one amino acid kinases inhibitor (IC50s: 11 to 15 nM for TAOK1 and 2, respectiv... | |||
T9377 | ASK1-IN-2 | Apoptosis , ASK , MAPK | |
ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM. ASK1-IN-2 can potentially be used as a therapeutic strategy for ulcerative colitis[1]. | |||
T3707 | GNE-3511 | GNE3511 | DNA Alkylation , MAPK |
GNE-3511 is a potent and selective dual leucine zipper kinase inhibitors. | |||
T4264 | Takinib | EDHS-206 | Apoptosis , MAPK |
Takinib (EDHS-206) is a specific and effective TAK1 inhibitor(IC50= 9.5 nM). | |||
T3468 | Tomivosertib | eFT508 | MNK , PD-1/PD-L1 |
Tomivosertib (eFT508) is a potent, highly selective MNK1 and MNK2 inhibitor with IC50 value of 1-2 nM. | |||
T14988 | CMPD1 | MAPK | |
CMPD1 is a non-ATP-competitive p38 MAPK-mediated MK2 phosphorylation inhibitor(apparent Ki (Kiapp): 330 nM). | |||
T4424 | SLV-2436 | SEL-201,SLV 2436,SEL201-88 | MNK |
SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM). |